oneKNEE - Prospective, Non-interventional, Multicenter PMCF-Study

NCT07682909 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1020

Last updated 2026-08-12

No results posted yet for this study

Summary

Safety and Clinical Performance in terms of clinical outcome of oneKNEE® (total knee arthroplasty TKA), evaluated 2 years after implantation.

Conditions

  • Arthroplasty
  • Arthroplasty Replacement, Knee
  • Prosthetic Joint Infections of Knee
  • TKA Outcomes

Interventions

DEVICE

oneKNEE®

Total knee prostheses

Sponsors & Collaborators

  • Aesculap AG

    lead INDUSTRY

Principal Investigators

  • Anne Postler, PD Dr. med · Städt. Klinikum Dresden

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-04-30
Primary Completion
2030-04-30
Completion
2031-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07682909 on ClinicalTrials.gov